Latest On Leap Therapeutics, Inc (LPTX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-15 12:07 EST | News | Leap Therapeutics GAAP EPS of -$0.32 misses by $0.23 | N/A |  |
| 2023-03-24 12:58 EST | News | Leap Therapeutics GAAP EPS of -$0.11 in-line | N/A | |
| 2023-01-19 20:31 EST | News | Leap rebounds as Astellas posts Phase 3 data for rival cancer candidate | N/A | |
| 2023-01-17 09:37 EST | News | Leap Therapeutics falls after all-stock deal to acquire Flame Biosciences | N/A | |
| 2022-11-16 14:24 EST | News | Leap Therapeutics,(LPTX) Investor Presentation - Slideshow | N/A | |
| 2022-11-14 11:22 EST | News | Leap Therapeutics GAAP EPS of -$0.13 misses by $0.01 | N/A | |
| 2022-08-12 21:44 EST | News | Leap Therapeutics GAAP EPS of -$0.15 misses by $0.05 | N/A | |
| 2022-07-12 11:37 EST | News | Leap Therapeutics begins trials of DKN-01 in gastric/colorectal cancers | N/A | |
| 2022-06-28 06:13 EST | News | Leap Therapeutics: 2 Catalysts With Cancer Drug DKN-01 In The 2nd Half Of 2022 | N/A | |
| 2022-05-13 19:49 EST | News | Leap Therapeutics GAAP EPS of -$0.09 beats by $0.01 | N/A | |
| 2022-03-11 14:12 EST | News | Leap Therapeutics GAAP EPS of -$0.10 beats by $0.01, revenue of $0.38M beats by $0.08M | N/A | |
| 2022-02-18 17:19 EST | News | Leap Therapeutics: Waiting For One More Leap | N/A | |
| 2022-01-31 19:28 EST | News | Leap Therapeutics forms partnership to develop companion diagnostic for cancer patients | N/A | |
| 2022-01-29 02:59 EST | News | Leap Therapeutics (LPTX) presents at 40th Annual JPMorgan Healthcare Conference (Slideshow) | N/A | |
| 2022-01-29 02:59 EST | News | Leap Therapeutics (LPTX) ASCO GI 2022 DisTinGuish Study Conference Call (Slideshow) | N/A | |
| 2022-01-19 14:38 EST | News | Leap Therapeutics updates Phase 2 data for DKN-01 combo in GIT cancer | N/A | |
| 2021-11-30 07:24 EST | News | Leap Therapeutics: What Prompted Prioritizing This Precision Oncology Company? | N/A | |
| 2021-11-13 00:10 EST | News | Leap Therapeutics EPS misses by $0.03, misses on revenue | N/A | |
| 2021-10-15 17:04 EST | News | Leap Therapeutics: Another Leap Coming Up | N/A | |
| 2021-10-13 03:53 EST | News | Leap Therapeutics: All On The Line | N/A | |
| 2021-09-25 05:37 EST | News | Leap Therapeutics (LPTX) ESMO 2021Virtual Congress Presentation - Slideshow | N/A | |
| 2021-09-23 06:47 EST | News | Leap Therapeutics plunges on stock and pre-funded warrants offering | N/A | |
| 2021-09-23 06:46 EST | News | Leap Therapeutics slips on pricing equity offering | N/A | |
| 2021-09-21 23:43 EST | News | Leap Therapeutics gains after announcing upcoming presentation for GIT cancer candidate | N/A | |
| 2021-09-21 23:34 EST | News | LAUR, LPTX, AERI and TWKS among after hours movers | N/A | |
| 2021-09-21 23:34 EST | News | Leap Therapeutics stock jumps 47% on positive DKN-01 + tislelizumab data in gastroesophageal cancer | N/A | |
| 2021-09-21 23:22 EST | News | MRIN, ALPN, SMMT and LPTX among after hours movers | N/A | |
| 2021-08-13 16:33 EST | News | Leap Therapeutics EPS in-line, beats on revenue | N/A | |
| 2021-04-12 22:35 EST | News | Flagship Biosciences and Leap Therapeutics ink RNAscope partnership | N/A | |
| 2021-03-22 09:24 EST | News | Leap Therapeutics stock surges on positive mid-stage DKN-01 data | N/A | |
| 2021-03-16 21:19 EST | Earnings Estimate | An EPS average of -$0.57 is estimated for the 2022 year. | Sell | |
| 2021-03-16 21:19 EST | Earnings Estimate | An EPS average of -$0.12 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-03-14 00:10 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-13 03:30 EST | News | Leap Therapeutics EPS in-line, misses on revenue | N/A | |
| 2021-03-03 00:24 EST | Analyst Rating | The Analyst Target Price has increased from $5.1 to $5.3. | Buy | |
| 2021-02-25 04:13 EST | Analyst Rating | The Analyst Target Price has decreased from $5.4 to $5.1. | Neutral | |
| 2021-02-24 11:55 EST | Analyst Rating | The Analyst Target Price has increased from $5.1 to $5.4. | Buy | |
| 2021-01-06 16:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 20:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-17 04:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-14 04:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-13 12:36 EST | Earnings Estimate | An EPS average of -$0.10 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-13 03:25 EST | News | Leap Therapeutics EPS beats by $0.04, beats on revenue | N/A | |
| 2020-11-07 16:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 13:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-25 23:08 EST | News | Leap Therapeutics Initiates Trial, And Other News: The Good, Bad And Ugly Of Biopharma | N/A | |
| 2020-09-24 18:13 EST | News | Leap Therapeutics rallies on accelerated review status for lead drug | N/A | |
| 2020-09-22 01:53 EST | News | Leap Therapeutics/BeiGene initiates DKN-01+tislelizumab combination mid-stage study in gastric cancer | N/A | |
| 2020-09-17 05:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-15 19:25 EST | News | Leap Therapeutics files for $150M mixed shelf | N/A | |
About Leap Therapeutics, Inc (LPTX):
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 that is in multiple clinical trials for treating esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, and prostate cancer. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
General
- Name Leap Therapeutics, Inc
- Symbol LPTX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 30
- Fiscal Year EndDecember
- IPO Date2017-01-25
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.leaptx.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 93.66
- Price/Book (Most Recent Quarter) 2.56
- Enterprise Value Revenue 69.95
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.46
- Next Year EPS Estimate -$0.57
- Next Quarter EPS Estimate -$0.10
- Operating Margin -1887%
- Return on Assets -57%
- Return on Equity -123%
- Revenue 1.5 million
- Earnings Per Share -$1.66
- Revenue Per Share $0.03
- Gross Profit 1.5 million
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 148.55 million
- EBITDA -34773000
- PEG Ratio 0.75
- Analyst Target Price $5.3
- Book Value Per Share $0.78
View More
Share Statistics
- Shares Outstanding 59.66 million
- Shares Float 37.28 million
- % Held by Insiders 1204%
- % Held by Institutions 59.02%
- Shares Short 1.22 million
- Shares Short Prior Month 1.06 million
- Short Ratio 1.24
- Short % of Float 3%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 1.34
- 52 Week High $3.24
- 52 Week Low $1.2
- 50 Day Moving Average 2.48
- 200 Day Moving Average 2.1
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Leap Therapeutics, Inc (LPTX) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Leap Therapeutics, Inc (LPTX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-12 | $N/A | -$0.09 | -$0.09 | -2.27% |
| 2020-09-30 | 2020-11-12 | $375000 | -$0.09 | -$0.13 | 29.69% |
| 2020-06-30 | 2020-08-13 | $N/A | -$0.12 | -$0.18 | 33.33% |
| 2020-03-31 | 2020-05-14 | $375000 | -$0.55 | -$0.25 | -124.49% |
| 2019-12-31 | 2020-03-16 | $N/A | -$0.32 | -$0.32 | -0.79% |
| 2019-09-30 | 2019-11-14 | $N/A | -$0.33 | -$0.33 | 0% |
| 2019-06-30 | 2019-08-09 | $N/A | -$0.37 | -$0.43 | 12.94% |
| 2019-03-31 | 2019-05-15 | $N/A | -$0.47 | -$0.41 | -14.63% |
| 2018-12-31 | 2018-12-31 | $N/A | $0.12 | -$0.57 | 121.05% |
| 2018-09-30 | 2018-11-09 | $N/A | -$0.45 | -$0.43 | -3.85% |
| 2018-06-30 | 2018-08-08 | $N/A | -$0.50 | -$0.49 | -2.04% |
| 2018-03-31 | 2018-05-11 | $N/A | -$0.85 | -$0.61 | -39.34% |
| 2017-12-31 | 2018-02-23 | $N/A | -$0.61 | -$0.82 | 25.61% |
| 2017-09-30 | 2017-11-13 | $N/A | -$0.73 | -$0.62 | -18.7% |
| 2017-06-30 | 2017-08-11 | $N/A | -$0.74 | -$0.71 | -4.23% |
| 2017-03-31 | 2017-05-12 | $N/A | -$1.39 | -$0.87 | -60.69% |
| 2016-12-31 | 2017-03-31 | $N/A | -$0.60 | -$0.80 | 25% |
Leap Therapeutics, Inc (LPTX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | 5.37 million | N/A | 4.6 million | 5.67 million |
| Income Before Tax | N/A | -7.06 million | N/A | -7.23 million | -8 million |
| Selling General Administrative | N/A | 2.51 million | N/A | 2.15 million | 2.6 million |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Ebit | N/A | -6.94 million | N/A | -7.02 million | -8.27 million |
| Operating Income | N/A | -7.28 million | N/A | -6.3 million | -8.27 million |
| Income Tax Expense | -2000 | N/A | N/A | N/A | -3000 |
| Total Revenue | N/A | 375000 | N/A | 375000 | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Total Other Income Expense Net | N/A | 237000 | N/A | -991000 | 270000 |
| Net Income From Continuing Operations | N/A | -7.06 million | N/A | -7.23 million | -8 million |
| Net Income Applicable to Common Shares | -6.71 million | N/A | -6.52 million | N/A | -8 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | N/A | -3.02 million | N/A | 364000 | -424000 |
| Total Cash Flow from Investing Activities | N/A | 25000 | N/A | 15000 | N/A |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | -385000 | N/A | 25.61 million | -19000 | 1.25 million |
| Change to Operating Activities | N/A | 248000 | N/A | 604000 | 97000 |
| Change in Cash | -6.91 million | N/A | 21.57 million | -6.17 million | -5.69 million |
| Total Cash from Operating Activities | -6.59 million | -9.45 million | -3.93 million | -5.89 million | -6.96 million |
| Depreciation | 99000 | N/A | 201000 | 10000 | 12000 |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | -20000 | -362000 |
| Change to Net Income | N/A | -292000 | N/A | 1.12 million | 1.29 million |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | 7.41 million | N/A | 10.78 million | 9.2 million |
| Total Stockholder Equity | N/A | 53.14 million | N/A | 17.96 million | -1.75 million |
| Other Current Liabilities | 1.5 million | N/A | N/A | N/A | N/A |
| Total Assets | N/A | 60.54 million | N/A | 28.74 million | 7.45 million |
| Common Stock | 60000 | N/A | 60000 | N/A | 24000 |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -222.99 million | -216.28 million | -209.22 million | -202.7 million | -195.17 million |
| Other Liabilities | 204000 | N/A | 750000 | N/A | 159000 |
| Other Assets | 1.5 million | N/A | 1.6 million | N/A | 2.06 million |
| Cash | N/A | 57.98 million | N/A | 25.47 million | 3.89 million |
| Total Current Liabilities | 7.37 million | 6.72 million | N/A | 9.2 million | 8.49 million |
| Other Stockholder Equity | -579000 | N/A | 121000 | N/A | 76000 |
| Property, Plant & Equipment | 593000 | N/A | 792000 | N/A | 1.15 million |
| Total Current Assets | 52.27 million | 58.4 million | N/A | 25.98 million | 4.24 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 46.65 million | N/A | 59.73 million | N/A | -1.75 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 2.72 million | 2.55 million | N/A | 4.93 million | 4.57 million |
Leap Therapeutics, Inc (LPTX) Chart:
Leap Therapeutics, Inc (LPTX) News:
Below you will find a list of latest news for Leap Therapeutics, Inc (LPTX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Leap Therapeutics, Inc (LPTX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 1 | 0 | CALL | 0 | 0 | 824.08 | TRUE | 0 | 0 |
| 2024-05-17 | 2 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 3 | 0.35 | CALL | 0 | 88 | 159.12 | TRUE | 0 | 0 |
| 2024-05-17 | 4 | 0.05 | CALL | 4 | 39 | 108.23 | FALSE | 0.05 | 0 |
| 2024-05-17 | 5 | 0.05 | CALL | 0 | 3 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 6 | 0.1 | CALL | 0 | 26 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2 | 0.05 | PUT | 0 | 60 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 3 | 0.35 | PUT | 10 | 69 | 190.35 | FALSE | 0.15 | 0.75 |
| 2024-05-17 | 4 | 0 | PUT | 0 | 0 | 208.75 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 6 | 0 | PUT | 0 | 0 | 372.35 | TRUE | 0 | 0 |
| 2024-05-17 | 7 | 0 | PUT | 0 | 0 | 300.56 | TRUE | 0 | 0 |
| 2024-06-21 | 1 | 2.43 | CALL | 0 | 3 | 462 | TRUE | 0 | 0 |
| 2024-06-21 | 2 | 0.8 | CALL | 0 | 2 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 3 | 0.9 | CALL | 0 | 115 | 156.56 | TRUE | 0 | 0 |
| 2024-06-21 | 4 | 0.3 | CALL | 0 | 76 | 152.94 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0.15 | CALL | 0 | 58 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 6 | 0.35 | CALL | 0 | 23 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7 | 0.25 | CALL | 0 | 43 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 8 | 0.1 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2 | 0.13 | PUT | 0 | 11 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 3 | 0.4 | PUT | 0 | 58 | 153.05 | FALSE | 0 | 0 |
| 2024-06-21 | 4 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0 | PUT | 0 | 0 | 218.18 | TRUE | 0 | 0 |
| 2024-06-21 | 6 | 0 | PUT | 0 | 0 | 327.78 | TRUE | 0 | 0 |
| 2024-06-21 | 7 | 0 | PUT | 0 | 0 | 248.5 | TRUE | 0 | 0 |
| 2024-06-21 | 8 | 0 | PUT | 0 | 0 | 392.24 | TRUE | 0 | 0 |
| 2024-09-20 | 1 | 0 | CALL | 0 | 0 | 269 | TRUE | 0 | 0 |
| 2024-09-20 | 2 | 1.4 | CALL | 0 | 50 | 0 | TRUE | 0 | 0 |
| 2024-09-20 | 3 | 1.5 | CALL | 0 | 375 | 330.97 | TRUE | 0 | 0 |
| 2024-09-20 | 4 | 0.77 | CALL | 0 | 7 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 5 | 0.4 | CALL | 0 | 43 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 6 | 0.4 | CALL | 0 | 3 | 136.56 | FALSE | 0 | 0 |
| 2024-09-20 | 7 | 0.27 | CALL | 0 | 22 | 424.89 | FALSE | 0 | 0 |
| 2024-09-20 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 2 | 0.35 | PUT | 0 | 5 | 130.68 | FALSE | 0 | 0 |
| 2024-09-20 | 3 | 0.77 | PUT | 0 | 71 | 110.07 | FALSE | 0 | 0 |
| 2024-09-20 | 4 | 1.35 | PUT | 0 | 1 | 127.68 | TRUE | 0 | 0 |
| 2024-09-20 | 5 | 2.25 | PUT | 0 | 1 | 113.73 | TRUE | 0 | 0 |
| 2024-09-20 | 6 | 0 | PUT | 0 | 0 | 137.39 | TRUE | 0 | 0 |
| 2024-09-20 | 7 | 0 | PUT | 0 | 0 | 146.51 | TRUE | 0 | 0 |
| 2024-12-20 | 1 | 0 | CALL | 0 | 0 | 207.18 | TRUE | 0 | 0 |
| 2024-12-20 | 2 | 0 | CALL | 0 | 0 | 373.51 | TRUE | 0 | 0 |
| 2024-12-20 | 3 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-12-20 | 4 | 1.1 | CALL | 0 | 3 | 137.96 | FALSE | 0 | 0 |
| 2024-12-20 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 6 | 0.55 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 3 | 1 | PUT | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 4 | 0 | PUT | 0 | 0 | 132.88 | TRUE | 0 | 0 |
| 2024-12-20 | 5 | 0 | PUT | 0 | 0 | 249.84 | TRUE | 0 | 0 |
| 2024-12-20 | 6 | 0 | PUT | 0 | 0 | 192.69 | TRUE | 0 | 0 |
Latest LPTX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $1.01 |
| Jun 13, 2022 7:59 PM EST | 40 | $1.015 |
| Jun 13, 2022 7:59 PM EST | 100 | $1.02 |
| Jun 13, 2022 7:59 PM EST | 5 | $1.01 |
| Jun 13, 2022 7:59 PM EST | 195 | $1.01 |
Leap Therapeutics, Inc (LPTX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920076856/0001104659-20-076856-index.htm |
| 2018-07-26 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1509745/000000000018022988/0000000000-18-022988-index.htm |
| 2018-08-10 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1509745/000000000018024784/0000000000-18-024784-index.htm |
| 2019-08-06 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1509745/000000000019012107/0000000000-19-012107-index.htm |
| 2018-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000005947818000198/0000059478-18-000198-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1509745/000005947819000077/0000059478-19-000077-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1509745/000031506619001161/0000315066-19-001161-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1509745/000031506620001085/0000315066-20-001085-index.htm |
| 2020-04-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000089924320011022/0000899243-20-011022-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000089924320017581/0000899243-20-017581-index.htm |
| 2018-09-07 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1509745/000104746918006052/0001047469-18-006052-index.htm |
| 2019-01-31 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1509745/000104746919000318/0001047469-19-000318-index.htm |
| 2019-02-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1509745/000104746919000333/0001047469-19-000333-index.htm |
| 2019-04-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1509745/000104746919001830/0001047469-19-001830-index.htm |
| 2019-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1509745/000104746919002698/0001047469-19-002698-index.htm |
| 2019-07-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1509745/000104746919004106/0001047469-19-004106-index.htm |
| 2019-07-31 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1509745/000104746919004464/0001047469-19-004464-index.htm |
| 2019-08-13 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1509745/000104746919004715/0001047469-19-004715-index.htm |
| 2020-01-28 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1509745/000104746920000550/0001047469-20-000550-index.htm |
| 2020-02-10 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1509745/000104746920000772/0001047469-20-000772-index.htm |
| 2020-03-16 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1509745/000104746920001500/0001047469-20-001500-index.htm |
| 2020-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1509745/000104746920002655/0001047469-20-002655-index.htm |
| 2020-06-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1509745/000104746920003667/0001047469-20-003667-index.htm |
| 2020-06-19 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1509745/000104746920003711/0001047469-20-003711-index.htm |
| 2018-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465918032365/0001104659-18-032365-index.htm |
| 2018-07-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465918046384/0001104659-18-046384-index.htm |
| 2018-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465918048857/0001104659-18-048857-index.htm |
| 2018-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465918048858/0001104659-18-048858-index.htm |
| 2018-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465918048859/0001104659-18-048859-index.htm |
| 2018-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465918048861/0001104659-18-048861-index.htm |
| 2018-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465918048862/0001104659-18-048862-index.htm |
| 2018-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465918048863/0001104659-18-048863-index.htm |
| 2018-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465918048864/0001104659-18-048864-index.htm |
| 2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1509745/000110465918050309/0001104659-18-050309-index.htm |
| 2018-08-08 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1509745/000110465918050310/0001104659-18-050310-index.htm |
| 2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465918050319/0001104659-18-050319-index.htm |
| 2018-08-08 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1509745/000110465918050321/0001104659-18-050321-index.htm |
| 2018-09-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465918055815/0001104659-18-055815-index.htm |
| 2018-09-10 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1509745/000110465918056029/0001104659-18-056029-index.htm |
| 2018-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465918063175/0001104659-18-063175-index.htm |
| 2018-11-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1509745/000110465918067133/0001104659-18-067133-index.htm |
| 2018-11-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465918067138/0001104659-18-067138-index.htm |
| 2018-11-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465918069217/0001104659-18-069217-index.htm |
| 2018-12-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465918072952/0001104659-18-072952-index.htm |
| 2018-12-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465918073109/0001104659-18-073109-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919000504/0001104659-19-000504-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919000506/0001104659-19-000506-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919000507/0001104659-19-000507-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919000508/0001104659-19-000508-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919000509/0001104659-19-000509-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919000511/0001104659-19-000511-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919000512/0001104659-19-000512-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919000513/0001104659-19-000513-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919000514/0001104659-19-000514-index.htm |
| 2019-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919001677/0001104659-19-001677-index.htm |
| 2019-01-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919004285/0001104659-19-004285-index.htm |
| 2019-01-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919004796/0001104659-19-004796-index.htm |
| 2019-02-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919004959/0001104659-19-004959-index.htm |
| 2019-02-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919005171/0001104659-19-005171-index.htm |
| 2019-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919005834/0001104659-19-005834-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919005835/0001104659-19-005835-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919005836/0001104659-19-005836-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919005837/0001104659-19-005837-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919005838/0001104659-19-005838-index.htm |
| 2019-02-08 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1509745/000110465919006865/0001104659-19-006865-index.htm |
| 2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919015410/0001104659-19-015410-index.htm |
| 2019-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919018969/0001104659-19-018969-index.htm |
| 2019-04-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1509745/000110465919018973/0001104659-19-018973-index.htm |
| 2019-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1509745/000110465919029515/0001104659-19-029515-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919029518/0001104659-19-029518-index.htm |
| 2019-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919030392/0001104659-19-030392-index.htm |
| 2019-06-11 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1509745/000110465919034806/0001104659-19-034806-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919035072/0001104659-19-035072-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919035073/0001104659-19-035073-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919035074/0001104659-19-035074-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919035075/0001104659-19-035075-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919035076/0001104659-19-035076-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919035077/0001104659-19-035077-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919035078/0001104659-19-035078-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919035079/0001104659-19-035079-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465919035081/0001104659-19-035081-index.htm |
| 2019-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919035828/0001104659-19-035828-index.htm |
| 2019-07-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919039889/0001104659-19-039889-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919044131/0001104659-19-044131-index.htm |
| 2019-08-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1509745/000110465919044336/0001104659-19-044336-index.htm |
| 2019-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1509745/000110465919045018/0001104659-19-045018-index.htm |
| 2019-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919045024/0001104659-19-045024-index.htm |
| 2019-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919050329/0001104659-19-050329-index.htm |
| 2019-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1509745/000110465919063689/0001104659-19-063689-index.htm |
| 2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919063698/0001104659-19-063698-index.htm |
| 2019-11-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465919066665/0001104659-19-066665-index.htm |
| 2020-01-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920000583/0001104659-20-000583-index.htm |
| 2020-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920002039/0001104659-20-002039-index.htm |
| 2020-02-13 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1509745/000110465920020256/0001104659-20-020256-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920029235/0001104659-20-029235-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920029236/0001104659-20-029236-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920029237/0001104659-20-029237-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920029239/0001104659-20-029239-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920029241/0001104659-20-029241-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920029242/0001104659-20-029242-index.htm |
| 2020-03-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920030492/0001104659-20-030492-index.htm |
| 2020-03-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920033628/0001104659-20-033628-index.htm |
| 2020-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920035463/0001104659-20-035463-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920035911/0001104659-20-035911-index.htm |
| 2020-03-20 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1509745/000110465920036435/0001104659-20-036435-index.htm |
| 2020-04-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920043887/0001104659-20-043887-index.htm |
| 2020-04-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920043888/0001104659-20-043888-index.htm |
| 2020-04-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920046072/0001104659-20-046072-index.htm |
| 2020-04-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920046073/0001104659-20-046073-index.htm |
| 2020-04-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920046074/0001104659-20-046074-index.htm |
| 2020-04-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920046075/0001104659-20-046075-index.htm |
| 2020-04-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920046076/0001104659-20-046076-index.htm |
| 2020-04-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920046077/0001104659-20-046077-index.htm |
| 2020-04-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920046078/0001104659-20-046078-index.htm |
| 2020-04-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920046079/0001104659-20-046079-index.htm |
| 2020-04-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920046080/0001104659-20-046080-index.htm |
| 2020-04-15 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920046854/0001104659-20-046854-index.htm |
| 2020-04-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920050023/0001104659-20-050023-index.htm |
| 2020-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1509745/000110465920061137/0001104659-20-061137-index.htm |
| 2020-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920061150/0001104659-20-061150-index.htm |
| 2020-06-11 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1509745/000110465920072491/0001104659-20-072491-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920072493/0001104659-20-072493-index.htm |
| 2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920074164/0001104659-20-074164-index.htm |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920074453/0001104659-20-074453-index.htm |
| 2020-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920075290/0001104659-20-075290-index.htm |
| 2020-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920075628/0001104659-20-075628-index.htm |
| 2020-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920076856/0001104659-20-076856-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920094191/0001104659-20-094191-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920094192/0001104659-20-094192-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920094193/0001104659-20-094193-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920094194/0001104659-20-094194-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920094195/0001104659-20-094195-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920094197/0001104659-20-094197-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920094199/0001104659-20-094199-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920094201/0001104659-20-094201-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920094203/0001104659-20-094203-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000110465920094204/0001104659-20-094204-index.htm |
| 2020-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1509745/000110465920094304/0001104659-20-094304-index.htm |
| 2020-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920094315/0001104659-20-094315-index.htm |
| 2020-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920104009/0001104659-20-104009-index.htm |
| 2020-09-14 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1509745/000110465920104928/0001104659-20-104928-index.htm |
| 2020-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920106756/0001104659-20-106756-index.htm |
| 2020-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1509745/000110465920108142/0001104659-20-108142-index.htm |
| 2020-10-14 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1509745/000110465920114977/0001104659-20-114977-index.htm |
| 2019-02-15 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1509745/000119312519042513/0001193125-19-042513-index.htm |
| 2020-01-21 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1509745/000119312520011112/0001193125-20-011112-index.htm |
| 2020-04-20 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1509745/000119312520112313/0001193125-20-112313-index.htm |
| 2020-08-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000156761920015870/0001567619-20-015870-index.htm |
| 2020-03-23 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1509745/000165130820000029/0001651308-20-000029-index.htm |
| 2020-03-23 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1509745/000165130820000030/0001651308-20-000030-index.htm |
| 2019-08-08 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1509745/999999999519001841/9999999995-19-001841-index.htm |
| 2020-10-16 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1509745/999999999520002888/9999999995-20-002888-index.htm |
Leap Therapeutics, Inc (LPTX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Leap Therapeutics, Inc (LPTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1204%Institutional Ownership: 5902%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-02-05 | AUGUSTINE LAWLOR | Chief Operating Officer | Buy | 571,428.00 | 1.75 | 999,999.00 | 4,114,804.00 | https://www.sec.gov/Archives/edgar/data/1509745/000110465919005837/0001104659-19-005837-index.htm |
| 2019-02-05 | Christopher Mirabelli | CEO, President, Chairman | Buy | 571,428.00 | 1.75 | 999,999.00 | 4,114,804.00 | https://www.sec.gov/Archives/edgar/data/1509745/000110465919005836/0001104659-19-005836-index.htm |
| 2019-02-05 | DOUGLAS E ONSI | CFO, GC, Treasurer & Secretary | Buy | 571,428.00 | 1.75 | 999,999.00 | 4,114,804.00 | https://www.sec.gov/Archives/edgar/data/1509745/000110465919005838/0001104659-19-005838-index.htm |
| 2019-02-05 | HealthCare Ventures IX, L.P. | 10% Share Holder | Buy | 571,428.00 | 1.75 | 999,999.00 | 4,144,804.00 | https://www.sec.gov/Archives/edgar/data/1509745/000110465919005835/0001104659-19-005835-index.htm |
| 2020-06-22 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 1,750,000.00 | 2.00 | 3,500,000.00 | 8,476,496.00 | https://www.sec.gov/Archives/edgar/data/1509745/000089924320017581/0000899243-20-017581-index.htm |